Tuesday, September 9, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Patrick Scholes Bullish on Ready Capital with Buy Rating and Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Patrick Scholes from Truist Securities is bullish on Ready Capital (NYSE:RC), giving it a Buy rating and raising the price target to $151. Scholes, known for his success rate of 51% and average return of 5.10% per rating, specializes in lodging and leisure equity research. His recent recommendations also include Buy ratings for Marriott Vacations Worldwide, Hilton Grand Vacations, and Bluegreen Vacations Holding. Truist Securities, a division of Truist Financial Corporation, provides comprehensive capital markets and investment banking services to corporate and institutional clients.

RC Stock Shows Positive Momentum Despite Challenges: Investors Should Exercise Caution and Monitor Performance

On March 1, 2024, RC stock showed some positive price momentum as it experienced a 4.00% increase, rising $0.34 from its previous closing price of $8.83. Despite this increase, RC is still trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating that the stock may still be facing some challenges in terms of overall performance. In pre-market trading, RC stock dropped slightly by $0.01, which could suggest some volatility in the stock’s price movement throughout the day. Investors should keep an eye on how the stock performs during regular trading hours to see if it can maintain its positive momentum or if it will face further fluctuations. It is important for investors to consider the broader market conditions and any company-specific news or events that could impact RC stock’s performance. By staying informed and conducting thorough research, investors can make more informed decisions about their investment strategies. Overall, while RC stock showed some positive price momentum on March 1, 2024, it is important for investors to exercise caution and closely monitor the stock’s performance to make informed decisions about their investments.

RC Stock Shows Promising Performance with 30.1% Revenue Increase in 2024

On March 1, 2024, RC stock showed promising performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.14 billion for the past year, which represents a significant increase of 30.1% compared to the previous year. The net income of RC also showed positive growth, with a reported net income of $339.45 million for the past year, reflecting an impressive increase of 83.78% compared to the previous year. Earnings per share (EPS) for RC stock also demonstrated strong performance, with an EPS of $2.22 for the past year, showing an increase of 47.23% compared to the previous year. Overall, the financial performance of RC stock on March 1, 2024, indicates positive growth in total revenue, net income, and earnings per share compared to the previous year. Investors may view this data as a positive indicator of the company’s financial health and potential for future growth.

Tags: RC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Market Capitalization

Analysts Bullish on MoonLake Immunotherapeutics Positive Outlook for MLTX

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Nvidias Transformation From Gaming Chips to AI Dominance

Wedbush Analyst Reaffirms Bullish Rating on ORIC Pharmaceuticals with Increased Price Target

Recommended

TGT stock news

Federated Hermes Inc. Reduces Position in KBR, Inc. Amid Positive Earnings Report

2 years ago
Automotive Stock Market Today

Canoo and Kingbee A Sustainable Partnership for EcoFriendly Work Vehicles

2 years ago
CSX stock news

Yousif Capital Management Decreases Ownership Stake in Viavi Solutions: A Look at Market Trends and Financial Indicators.

2 years ago
Technology Artificial intelligence Market Capitalization

Super Micro Computers Stock Soars on Growing Demand for AI Servers

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple BA BioNTech Broadcom C Coinbase DIS Eli Lilly Fiserv IBM Intel Iovance Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF MSFT NIO Nvidia Opendoor Oracle Palantir PayPal Pepsi Robinhood Rocket Lab USA Salesforce SMCI Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Valero Energy’s Dual Strategy: Traditional Refining Meets Green Innovation

Navigating Headwinds: Wells Fargo’s Dividend Strategy Amid Interest Rate Challenges

CF Industries: A Company at a Crossroads Amid Diverging Market Views

Limoneira Shares Approach Earnings Amid Deep Pessimism

Enact Holdings Reaches New Peak with Dividend Payout

Strategic Shift Clears Path for HarborOne and Eastern Bankshares Merger

Trending

Allogene Therapeutics Stock
Analysis

Allogene Therapeutics Stock: Navigating Volatility Amid Clinical Progress

by Andreas Sommer
September 9, 2025
0

Shares of Allogene Therapeutics have demonstrated significant volatility, with a recent 3.6% gain on September 8th starkly...

Henry Stock

Rewriting the Rules of Customer Loyalty: Jack Henry’s Stock-Based Rewards Strategy

September 9, 2025
Altimmune Stock

Altimmune Navigates Legal Challenges Amid Investor Conference

September 9, 2025
Valero Energy Stock

Valero Energy’s Dual Strategy: Traditional Refining Meets Green Innovation

September 9, 2025
Wells Fargo Stock

Navigating Headwinds: Wells Fargo’s Dividend Strategy Amid Interest Rate Challenges

September 9, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Allogene Therapeutics Stock: Navigating Volatility Amid Clinical Progress September 9, 2025
  • Rewriting the Rules of Customer Loyalty: Jack Henry’s Stock-Based Rewards Strategy September 9, 2025
  • Altimmune Navigates Legal Challenges Amid Investor Conference September 9, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com